Abstract
This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Current Bioactive Compounds
Title:Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract
Volume: 12 Issue: 1
Author(s): Fatah Keffous, Nasser Belboukhari, Houria Djaradi, Abdelkrim Cheriti, Khaled Sekkoum and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Abstract: This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Export Options
About this article
Cite this article as:
Keffous Fatah, Belboukhari Nasser, Djaradi Houria, Cheriti Abdelkrim, Sekkoum Khaled and Y. Aboul-Enein Hassan, Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160210230707
DOI https://dx.doi.org/10.2174/1573407212666160210230707 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hematopoietic Growth Factors Support in the Elderly Cancer Patients Treated with Antiblastic Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan
Current Drug Safety Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Hydrophilic Carotenoid Amphiphiles: Methods of Synthesis and Biological Applications
Mini-Reviews in Medicinal Chemistry Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?
Current Medicinal Chemistry - Anti-Infective Agents Current Status of Complementary and Alternative Medicine in the Treatment of Rheumatic Disease Pain
Current Rheumatology Reviews Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design Anti-Inflammatory and Anti-Allergy Drugs in Rhinosinusitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis
Current HIV Research The Evidence Base for Revascularisation of Chronic Total Occlusions
Current Cardiology Reviews Vitamin D and Sepsis: From Associations to Causal Connections
Inflammation & Allergy - Drug Targets (Discontinued) Lipid Lowering Agents, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study
Current Neurovascular Research